BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21036730)

  • 1. Overexpression of tissue inhibitor of metalloproteinase-1 gene correlates with poor outcomes in colorectal cancer.
    Inagaki D; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Yamada T; Yamamoto N; Sato T; Shiozawa M; Morinaga S; Akaike M; Fujii S; Numata K; Kunisaki C; Rino Y; Tanaka K; Masuda M; Imada T
    Anticancer Res; 2010 Oct; 30(10):4127-30. PubMed ID: 21036730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
    Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
    Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of MT1-MMP gene expression to outcomes in colorectal cancer.
    Kanazawa A; Oshima T; Yoshihara K; Tamura S; Yamada T; Inagaki D; Sato T; Yamamoto N; Shiozawa M; Morinaga S; Akaike M; Kunisaki C; Tanaka K; Masuda M; Imada T
    J Surg Oncol; 2010 Nov; 102(6):571-5. PubMed ID: 20721961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
    Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
    Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
    Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer.
    Thiéfin G; Dupont A; Guillou PJ; Vitry F; Bouche O; Yaziji N; Lagarde S; Maquart FX; Palot JP; Hornebeck W; Diebold MD
    Anticancer Res; 2007; 27(1B):583-8. PubMed ID: 17348445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
    Yamada T; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Inagaki D; Yamamoto N; Sato T; Fujii S; Numata K; Kunisaki C; Shiozawa M; Morinaga S; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
    Anticancer Res; 2010 Jul; 30(7):2693-9. PubMed ID: 20683000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TIMP-1 splice variant transcript: possible role in regulation of TIMP-1 expression.
    Obro NF; Lademann U; Birkenkamp-Demtroder K; Holten-Andersen L; Brünner N; Offenberg H
    Cancer Lett; 2008 Apr; 262(1):64-70. PubMed ID: 18180096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
    Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H; Lin QD; Qiao C
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between RegIV gene expression to outcomes in colorectal cancer.
    Numata M; Oshima T; Yoshihara K; Watanabe T; Tsuchida K; Tamagawa H; Yamamoto N; Shiozawa M; Morinaga S; Akaike M; Kunisaki C; Rino Y; Tanaka K; Masuda M; Imada T
    J Surg Oncol; 2011 Aug; 104(2):205-9. PubMed ID: 21381041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
    Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
    Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
    J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.